ly 311727 has been researched along with we 201 in 1 studies
| Studies (ly 311727) | Trials (ly 311727) | Recent Studies (post-2010) (ly 311727) | Studies (we 201) | Trials (we 201) | Recent Studies (post-2010) (we 201) |
|---|---|---|---|---|---|
| 33 | 1 | 6 | 115 | 1 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbibe, L; Béréziat, G; Faure, G; Havet, N; Koumanov, K; Longacre, S; Rougeot, C; Touqui, L; Vargaftig, BB; Vial, D; Voelker, DR; Wolf, C | 1 |
1 other study(ies) available for ly 311727 and we 201
| Article | Year |
|---|---|
Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
Topics: Acute Disease; Animals; Biosensing Techniques; Bronchoalveolar Lavage Fluid; Fatty Acids; Group II Phospholipases A2; Guinea Pigs; Hydrolysis; Indoles; Lipopolysaccharides; Lung Diseases; Lysophosphatidylcholines; Male; Palmitic Acid; Phospholipases A; Phospholipases A2; Protein Binding; Proteolipids; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants | 1998 |